Avantor, Inc. $AVTR Shares Sold by Royal Bank of Canada

Royal Bank of Canada lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 21.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 230,629 shares of the company’s stock after selling 63,355 shares during the period. Royal Bank of Canada’s holdings in Avantor were worth $1,808,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Private Trust Co. NA raised its stake in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after acquiring an additional 905 shares during the last quarter. Osaic Holdings Inc. increased its holdings in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares in the last quarter. UMB Bank n.a. raised its position in shares of Avantor by 17.6% in the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after purchasing an additional 1,101 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Performance

Shares of AVTR stock opened at $13.36 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93. The business’s 50 day moving average is $11.35 and its two-hundred day moving average is $9.57. The company has a market capitalization of $9.04 billion, a P/E ratio of -15.91, a P/E/G ratio of 10.29 and a beta of 0.89.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The business’s revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts expect that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Morgan Stanley lifted their price objective on shares of Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Finally, TD Cowen restated a “hold” rating on shares of Avantor in a research note on Wednesday, July 15th. Two analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.00.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.